Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

AUMED a.s. founded a new company AUMED Immunology a.s.. AUMED, a.s. is the sole shareholder of the newly formed company. The company AUMED Immunology a.s. was founded with the aim of registering and marketing a new medicinal product containing transfer factor as an active medicinal substance in the form of an oral lyophilized tablet. The new medicinal product will be based on the results of own research activities in the field of transfer factors (more detailed information here). The registration plan for a newly developed medicinal product belongs to the long-term business concept and strategy of AUMED, a.s.. You can learn more about the registration process and clinical trials on AUMED Immunology’s own website. (

Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness

Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s